REFERENCES
1. Allan GM, Arroll B. Prevention and treatment of the common cold:
making sense of the evidence. Cmaj. Feb 18 2014;186(3):190-199.
2. Fashner J, Ericson K, Werner S. Treatment of the common cold in
children and adults. Am Fam Physician. Jul 15 2012;86(2):153-159.
3. Heikkinen T, Järvinen A. The common cold. Lancet. Jan 4
2003;361(9351):51-59.
4. Bramley TJ, Lerner D, Sames M. Productivity losses related to the
common cold. J. Occup. Environ. Med. Sep 2002;44(9):822-829.
5. Kim SY. Drug therapy for the common cold. J Korean Med Assoc.2 2015;58(2):147-153.
6. Robohm C, Ruff C. Diagnosis and treatment of the common cold in
pediatric patients. Jaapa. Dec 2012;25(12):43-47.
7. DeGeorge KC, Ring DJ, Dalrymple SN. Treatment of the Common Cold.Am Fam Physician. Sep 1 2019;100(5):281-289.
8. De Sutter AI, Saraswat A, van Driel ML. Antihistamines for the common
cold. Cochrane Database Syst Rev. Nov 29 2015(11):Cd009345.
9. Deckx L, De Sutter AI, Guo L, Mir NA, van Driel ML. Nasal
decongestants in monotherapy for the common cold. Cochrane
Database Syst Rev. Oct 17 2016;10(10):Cd009612.
10. Petrin A, Schmidt R. [Antitussives and expectorants-a review
(author’s transl)]. Schweiz Rundsch Med Prax. Jan 15
1974;63(2):30-36.
11. Rubin BK. Mucolytics, expectorants, and mucokinetic medications.Respir Care. Jul 2007;52(7):859-865.
12. Sander K, Zettl H, Schubert-Zsilavecz M, Stark H. [Antitussives
and expectorants]. Pharm Unserer Zeit. 2008;37(6):462-471.
13. Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications
for acute cough in children and adults in community settings.Cochrane Database Syst Rev. Nov 24 2014;2014(11):Cd001831.
14. Sutter AI, Lemiengre M, Campbell H, Mackinnon HF. Antihistamines for
the common cold. Cochrane Database Syst Rev. 2003(3):Cd001267.
15. Byeon JJ. Prescription of Digestive System Drugs to the Patients
with No Digestive Symptoms. J Korean Acad Fam Med. 1
1997;18(1):78-84.
16. Cho HJ, Kim CB. Prescription behaviours of office-based doctors to
standardized common cold patients in Korea. Pharmacoepidemiol.
Drug Saf. Jul-Aug 2002;11(5):401-405.
17. Eun C, Sukyeong K. Prescribing Superfluous Gastroprotective Agents:
an Indicator ofPolypharmacy. Korean J Clin Pharm.2011;21(2):156-160.
18. Kenealy T, Arroll B. Antibiotics for the common cold and acute
purulent rhinitis. Cochrane Database Syst Rev. Jun 4
2013;2013(6):Cd000247.
19. Shin SM, Shin JY, Kim MH, Lee SH, Choi S, Park BJ. Prevalence of
antibiotic use for pediatric acute upper respiratory tract infections in
Korea. J Korean Med Sci. May 2015;30(5):617-624.
20. Song YK, Han N, Kim MG, et al. A national pharmacoepidemiological
study of antibiotic use in Korean paediatric outpatients. Arch Dis
Child. Jul 2017;102(7):660-666.
21. Spurling GK, Del Mar CB, Dooley L, Foxlee R, Farley R. Delayed
antibiotic prescriptions for respiratory infections. Cochrane
Database Syst Rev. Sep 7 2017;9(9):Cd004417.
22. Youngster I, Avorn J, Belleudi V, et al. Antibiotic Use in Children
- A Cross-National Analysis of 6 Countries. J Pediatr. Mar
2017;182:239-244.e231.
23. Kim JA, Yoon S, Kim LY, Kim DS. Towards Actualizing the Value
Potential of Korea Health Insurance Review and Assessment (HIRA) Data as
a Resource for Health Research: Strengths, Limitations, Applications,
and Strategies for Optimal Use of HIRA Data. J Korean Med Sci.May 2017;32(5):718-728.
24. Kim L, Kim JA, Kim S. A guide for the utilisation of Health
Insurance Review and Assessment Service National Patient Samples.Epidemiol Health. 2014;36:e2014008.
25. RAO AS, CAMILLERI M. Review article: metoclopramide and tardive
dyskinesia. Aliment. Pharmacol. Ther. 2010;31(1):11-19.
26. Chen CH, Lin CL, Kao CH. Gastroesophageal reflux disease with proton
pump inhibitor use is associated with an increased risk of osteoporosis:
a nationwide population-based analysis. Osteoporos. Int.2016/06/01 2016;27(6):2117-2126.
27. Lin S-M, Yang S-H, Liang C-C, Huang H-K. Proton pump inhibitor use
and the risk of osteoporosis and fracture in stroke patients: a
population-based cohort study. Osteoporos. Int.2018;29(1):153-162.
28. van der Hoorn MMC, Tett SE, de Vries OJ, Dobson AJ, Peeters GMEE.
The effect of dose and type of proton pump inhibitor use on risk of
fractures and osteoporosis treatment in older Australian women: A
prospective cohort study. Bone. 2015/12/01/ 2015;81:675-682.
29. Yu EW, Bauer SR, Bain PA, Bauer DC. Proton Pump Inhibitors and Risk
of Fractures: A Meta-Analysis of 11 International Studies. The
American Journal of Medicine. 2011/06/01/ 2011;124(6):519-526.
30. Filion KB, Chateau D, Targownik LE, et al. Proton pump inhibitors
and the risk of hospitalisation for community-acquired pneumonia:
replicated cohort studies with meta-analysis. Gut.2014;63(4):552-558.
31. Giuliano C, Wilhelm SM, Kale-Pradhan PB. Are proton pump inhibitors
associated with the development of community-acquired pneumonia? A
meta-analysis. Expert Rev. Clin. Pharmacol. 2012/05/01
2012;5(3):337-344.
32. JOHNSTONE J, NERENBERG K, LOEB M. Meta-analysis: proton pump
inhibitor use and the risk of community-acquired pneumonia.Aliment. Pharmacol. Ther. 2010;31(11):1165-1177.
33. Othman F, Crooks CJ, Card TR. Community acquired pneumonia incidence
before and after proton pump inhibitor prescription: population based
study. BMJ. 2016;355:i5813.
34. Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium
difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A
Meta-Analysis. Official journal of the American College of
Gastroenterology | ACG. 2012;107(7):1001-1010.
35. McDonald EG, Milligan J, Frenette C, Lee TC. Continuous Proton Pump
Inhibitor Therapy and the Associated Risk of Recurrent Clostridium
difficile Infection. JAMA Internal Medicine. 2015;175(5):784-791.
36. DEN ELZEN WPJ, GROENEVELD Y, DE RUIJTER W, et al. Long-term use of
proton pump inhibitors and vitamin B12 status in elderly individuals.Aliment. Pharmacol. Ther. 2008;27(6):491-497.
37. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and
histamine 2 receptor antagonist use and vitamin B12 deficiency.Jama. 2013;310(22):2435-2442.
38. Høj K, Mygind A, Livbjerg S, Bro F. [Deprescribing of
inappropriate medication in primary care]. Ugeskr Laeger. Jun
10 2019;181(24).
39. Ng BJ, Le Couteur DG, Hilmer SN. Deprescribing Benzodiazepines in
Older Patients: Impact of Interventions Targeting Physicians,
Pharmacists, and Patients. Drugs Aging. Jun 2018;35(6):493-521.
40. Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The
feasibility and effect of deprescribing in older adults on mortality and
health: a systematic review and meta-analysis. Br J Clin
Pharmacol. Sep 2016;82(3):583-623.
41. Thillainadesan J, Gnjidic D, Green S, Hilmer SN. Impact of
Deprescribing Interventions in Older Hospitalised Patients on
Prescribing and Clinical Outcomes: A Systematic Review of Randomised
Trials. Drugs Aging. Apr 2018;35(4):303-319.
42. Endsley S. Deprescribing Unnecessary Medications: A Four-Part
Process. Fam Pract Manag. May/Jun 2018;25(3):28-32.
43. McGrath K, Hajjar ER, Kumar C, Hwang C, Salzman B. Deprescribing: A
simple method for reducing polypharmacy. J Fam Pract. Jul
2017;66(7):436-445.
44. Sung NJ, Suh S-Y, Lee DW, et al. Patient’s assessment of primary
care of medical institutions in South Korea by structural type.Int. J. Qual. Health Care. 2010;22(6):493-499.
45. An AR, Kim K, Lee J-H, Sung N-J, Lee S-i, Hyun MK. Having a usual
source of care and its associated factors in Korean adults: a
cross-sectional study of the 2012 Korea Health Panel Survey. BMC
Fam. Pract. 2016/11/29 2016;17(1):167.
46. Scheiman JM. NSAID-induced Gastrointestinal Injury: A Focused Update
for Clinicians. J Clin Gastroenterol. Jan 2016;50(1):5-10.
47. García-Rayado G, Navarro M, Lanas A. NSAID induced gastrointestinal
damage and designing GI-sparing NSAIDs. Expert Rev Clin
Pharmacol. Oct 2018;11(10):1031-1043.
48. Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal
antiinflammatory drugs: an update of gastrointestinal, cardiovascular
and renal complications. J Pharm Pharm Sci. 2013;16(5):821-847.
49. Kim S, Kim MS, You SH, Jung SY. Conducting and Reporting a Clinical
Research Using Korean Healthcare Claims Database. Korean J Fam
Med. May 2020;41(3):146-152.
50. Cho E, Kim, Su-Kyeong Prescribing Superfluous Gastroprotective
Agents: an Indicator of Polypharmacy. Korean Journal of Clinical
Pharmacy. 2011;v.21, no.2.
51. Sumit Patel PD, Rima B Shah, Sagun V Desai. Prescribing pattern of
cough and cold medicines in central Gujarat. International Journal
of Medical Science and Public Health. 2013.